Kesios Therapeutics
VerifiedDevelops novel therapeutics for the treatment of multiple myeloma and other cancers.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$119—178m (Dealroom.co estimates Aug 2021.)
Company register number 08143109
Cambourne England (HQ)
No columns specified